department of pharmacology





Foresight Advisory Group

The Foresight Group is an assembly of learned and accomplished
individuals whose broad perspectives and keen insights are an asset to
procuring resources, to defining the focal areas of research, to
facilitating the translation of basic science into clinical utility,
and to fostering education in the pharmacological sciences in the
academic and business realms as well as the community.

 

Members

Adamis

Anthony P. Adamis, MD
VP, Global Head of Ophthalmology
Genentech, Inc.
South San Francisco, CA

Stefanski

Ben S. Stefanski, II
President,
Polish American Cultural Center
Board Member and Full Time Volunteer,
Pulaski Franciscan Community Development Corporation

Kubota

Ryo Kubota MD, PhD
Chairman, President, and CEO 
Acucela Inc.
Seattle, Washington

DiCorleto

Dr. Paul E. DiCorleto
Sherwin-Page Chairman
Cleveland Clinic Lerner Research Institute

Burley

Stephen K. Burley M.D., D.Phil., F.R.S.C.
Chief Scientific Officer and Senior Vice-President Research
SGX Pharmaceuticals, Inc.
San Diego, CA

Copeland

Robert A. Copeland, Ph.D.
Vice President
Enzymology & Mechanistic Pharmacology GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceutical Company

Murad

Ferid Murad, M.D. Ph.D.,
Nobel Laureate
Professor & Director,
Institute of Molecular Medicine
The University of Texas Health Science Center at Houston

Prichard

David C. U'Prichard, Ph.D.
President,
Druid Consulting LLC

Hohman

Thomas C. Hohman, Ph.D.,
Vice President of Retina Translation Medicine Allergan, Inc.

Dixit.jpg

Visvha Dixit, Ph.D.,
Vice-President, Research
Early Discovery Research Department
Genentech, Inc.
Vishva Dixit, Ph.D.,
Vice-President, Research